These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 26285754)

  • 21. Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy.
    McLeod DS; Taomoto M; Cao J; Zhu Z; Witte L; Lutty GA
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):474-82. PubMed ID: 11818393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole mount immunofluorescent staining of the neonatal mouse retina to investigate angiogenesis in vivo.
    Tual-Chalot S; Allinson KR; Fruttiger M; Arthur HM
    J Vis Exp; 2013 Jul; (77):e50546. PubMed ID: 23892721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CAI is a potent inhibitor of neovascularization and imparts neuroprotection in a mouse model of ischemic retinopathy.
    Franklin AJ; Jetton TL; Kuchemann CL; Russell SR; Kohn EC
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3756-66. PubMed ID: 15452087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiostatin inhibits pathological but not physiological retinal angiogenesis.
    Drixler TA; Borel Rinkes IH; Ritchie ED; Treffers FW; van Vroonhoven TJ; Gebbink MF; Voest EE
    Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3325-30. PubMed ID: 11726640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time-lapse imaging of retinal angiogenesis reveals decreased development and progression of neovascular sprouting by anecortave desacetate.
    Unoki N; Murakami T; Ogino K; Nukada M; Yoshimura N
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2347-55. PubMed ID: 19959648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A computational tool for quantitative analysis of vascular networks.
    Zudaire E; Gambardella L; Kurcz C; Vermeren S
    PLoS One; 2011; 6(11):e27385. PubMed ID: 22110636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and pathology of the hyaloid, choroidal and retinal vasculature.
    Saint-Geniez M; D'Amore PA
    Int J Dev Biol; 2004; 48(8-9):1045-58. PubMed ID: 15558494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors.
    Tobe T; Okamoto N; Vinores MA; Derevjanik NL; Vinores SA; Zack DJ; Campochiaro PA
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):180-8. PubMed ID: 9430560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pleiotropic effects of YC-1 selectively inhibit pathological retinal neovascularization and promote physiological revascularization in a mouse model of oxygen-induced retinopathy.
    DeNiro M; Al-Halafi A; Al-Mohanna FH; Alsmadi O; Al-Mohanna FA
    Mol Pharmacol; 2010 Mar; 77(3):348-67. PubMed ID: 20008515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal expression of angiogenesis-related genes in developing neonatal rodent retina: a novel in vivo model to study cerebral vascular development.
    Ozduman K; Ozkan A; Yildirim O; Pamir MN; Gunel M; Kilic T
    Neurosurgery; 2010 Mar; 66(3):538-43; discussion 543. PubMed ID: 20173549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Angiogenesis - possibilities, problems and perspectives].
    Kurzyk A
    Postepy Biochem; 2015; 61(1):25-34. PubMed ID: 26281351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic angiogenesis: translating experimental concepts to medically relevant goals.
    Emanueli C; Madeddu P
    Vascul Pharmacol; 2006 Nov; 45(5):334-9. PubMed ID: 17008132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In situ calcium mapping in the mouse retina via time-of-flight secondary ion mass spectrometry: modulation of retinal angiogenesis by calcium ion in development and oxygen-induced retinopathy.
    Kim JH; Kim JH; Yu YS; Kim DH; Lee TG; Moon DW; Kim KW
    Biochem Cell Biol; 2008 Oct; 86(5):459-67. PubMed ID: 18923547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of the retinal vasculature.
    Fruttiger M
    Angiogenesis; 2007; 10(2):77-88. PubMed ID: 17322966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antagonists of integrin alpha v beta 3 inhibit retinal neovascularization in a murine model.
    Luna J; Tobe T; Mousa SA; Reilly TM; Campochiaro PA
    Lab Invest; 1996 Oct; 75(4):563-73. PubMed ID: 8874387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visualization of mouse embryo angiogenesis by fluorescence-based staining.
    Liu Y; Antonyak M; Peng X
    Methods Mol Biol; 2012; 843():79-85. PubMed ID: 22222523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new mechanism of blood vessel growth - hope for new treatment strategies.
    Kilarski WW; Gerwins P
    Discov Med; 2009 Jun; 8(40):23-7. PubMed ID: 19772838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization.
    Ishida S; Usui T; Yamashiro K; Kaji Y; Amano S; Ogura Y; Hida T; Oguchi Y; Ambati J; Miller JW; Gragoudas ES; Ng YS; D'Amore PA; Shima DT; Adamis AP
    J Exp Med; 2003 Aug; 198(3):483-9. PubMed ID: 12900522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mouse retina as an angiogenesis model.
    Stahl A; Connor KM; Sapieha P; Chen J; Dennison RJ; Krah NM; Seaward MR; Willett KL; Aderman CM; Guerin KI; Hua J; Löfqvist C; Hellström A; Smith LE
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):2813-26. PubMed ID: 20484600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The temporal and spatial vascular endothelial growth factor expression in retinal vasculogenesis of rat neonates.
    Murata T; Nakagawa K; Khalil A; Ishibashi T; Inomata H; Sueishi K
    Lab Invest; 1996 Jan; 74(1):68-77. PubMed ID: 8569199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.